Charles River Laboratories International (CRL) EBITDA Margin Growth (3y) (2012 - 2026)
Charles River Laboratories International (CRL) EBITDA Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -168.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 3,294.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -56.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -247.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 360.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 2,862.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 146.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 333.00 |
| 10 | Charles River Laboratories International | 14.28 Bn | 14.09 Bn | 452.07 Mn | -362.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -362.00 |
| Dec 27, 2025 | -4,340.00 |
| Sep 27, 2025 | -195.00 |
| Jun 28, 2025 | -956.00 |
| Mar 29, 2025 | -869.00 |
| Dec 28, 2024 | -3,582.00 |
| Sep 28, 2024 | -576.00 |
| Jun 29, 2024 | -26.00 |
| Mar 30, 2024 | -255.00 |
| Dec 30, 2023 | -318.00 |
| Sep 30, 2023 | -310.00 |
| Jul 1, 2023 | 432.00 |
| Apr 1, 2023 | 298.00 |
| Dec 31, 2022 | -85.00 |
| Sep 24, 2022 | 137.00 |
| Jun 25, 2022 | 713.00 |
| Mar 26, 2022 | 473.00 |
| Dec 25, 2021 | 206.00 |
| Sep 25, 2021 | 298.00 |
| Jun 26, 2021 | 193.00 |